Since our inception, ARCHIMED has supported healthcare companies in Europe expanding into the US, and American companies navigating the complexities of European markets.

Opening our Tokyo office was a natural step, as Japan ranks among the top three healthcare markets globally. With its world-class healthcare and life sciences technologies, Japan’s healthcare sector offers solutions that can benefit patients worldwide.

I relocated to Tokyo to serve as a bridge connecting our team, ARCHIMED companies, and healthcare networks across continents. Together with our partners, we aim to help Japanese healthcare companies create lasting value for Japanese healthcare businesses and patients.

Vincent Guillaumot
ARCHIMED Co-founder and Tokyo Office

Founded in 2014, ARCHIMED was built on the belief that a healthcare-focused fund is the most effective way to create lasting value—for companies, investors, patients, and society.

We partner with healthcare entrepreneurs and professionals, scientists, industry experts, and investors, serving as a strategic investment partner to navigate one of the world’s most complex and highly regulated healthcare markets, including Japan.

We fund ambitious healthcare industries and support them to grow value thanks to our five key value creation levers.

• • Internationalization
  • Business development
  • Product & service range expansion
  • M&A and add-on acquisitions
  • Innovation

Strategically combining these growth levers, we generate strong financial returns while improving health outcomes for people, patients, animals, and the environment around the world.

At ARCHIMED, value creation goes beyond financial returns. Through the EURÊKA Foundation, funded by 5% of the value we generate, we support vulnerable communities and finance innovative research into underserved diseases.

All EURÊKA projects are championed by ARCHIMED employees, who contribute their time, energy, and networks to the non-profits supported by the Foundation. This employee engagement reminds us that we are part of the broader healthcare ecosystem.

In Japan, the Foundation supports Clubhouse Japan, an organization dedicated to empowering individuals living with mental illness. It also funds scientific research at the University of Tokyo, focused on advancing the understanding and treatment of gastric cancer.